Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Good Girl Rx vs OurView Health

Good Girl Rx
Graded #277

Lower grade

vs+5.499999999999993
OurView Health
Graded #162

Higher grade

The verdict

OurView Health takes it — 67.6/100 to 62.1/100.

OurView Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. OurView (OurView Health) is a 100% online multi-vertical telehealth service with an Our View Savings Club membership offering pharmacy-direct pricing on U.S.-compounded medications.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOurView Health +48
28
76
Dose & formulationGood Girl Rx +24
88
64
Clinical oversightGood Girl Rx +2
81
79
Labs & monitoringOurView Health +1
52
53
FulfillmentGood Girl Rx +15
85
70
Contract termsOurView Health +4
41
45
Good Girl Rx · left barOurView Health · right bar

The numbers

MetricGood Girl RxOurView Health
WeighScore62.1/10067.6/100
GradeCC
Scorecard rank#277#162
Semaglutide$79/mo (microdose tier, 12-month plan, compounded)$75/mo (starting dose, compounded)
Tirzepatide$139/mo (microdose tier, 12-month plan, compounded)$135/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Good Girl Rx

Graded #277 · C

Strengths

  • LegitScript certified
  • Multiple formats — injectable, microdose, and ODT pills — for both semaglutide and tirzepatide
  • Dispensed by licensed 503A or 503B pharmacies
  • Limited brand-name options available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • Named legal entity with a Nashville address

Where it loses points

  • The advertised rates require twelve months paid up front; billed month to month the same products are $184 and $244, roughly 2.3 times as much
  • Every plan is prepaid — the discount exists only on the 3-, 6- and 12-month terms
  • The priced products are microdoses, not labelled therapeutic doses; the standard compounded semaglutide is $134/mo and also needs a year up front
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
OurView Health

Graded #162 · C

Strengths

  • Low starting prices via the Savings Club — compounded semaglutide from $75, tirzepatide from $135
  • Clear product pricing with no contracts; medication shipped to your door (30-day supply)
  • Full legal suite published (Terms, Privacy, HIPAA Notice, Returns & Refunds)
  • Discloses meds are compounded by a licensed third-party pharmacy; multi-vertical (TRT, HRT, BHRT, peptides)

Where it loses points

  • A comparison table on the site quotes $90 'without membership' against $75 'with membership' while the product cards say 'No membership' and the cart charges $75 without one — the provider contradicts itself on whether a membership exists
  • Both figures are starting-dose rates; the cost of a titrated dose is published as a ladder rather than a single price
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard